Conditional Knockout of Hypoxia-Inducible Factor 1-Alpha in Tumor-Infiltrating Neutrophils Protects against Pancreatic Ductal Adenocarcinoma
Open accessThe DOI matches its Crossref record; 71 of the 72 references it cites were found in a registry or an index.
Abstract
Large numbers of neutrophils infiltrate tumors and comprise a notable component of the inflammatory tumor microenvironment. While it is established that tumor cells exhibit the Warburg effect for energy production, the contribution of the neutrophil metabolic state to tumorigenesis is unknown. Here, we investigated whether neutrophil infiltration and metabolic status promotes tumor progression in an orthotopic mouse model of pancreatic ductal adenocarcinoma (PDAC). We observed a large increase in the proportion of neutrophils in the blood and tumor upon orthotopic transplantation. Intriguingly, these tumor-infiltrating neutrophils up-regulated glycolytic factors and hypoxia-inducible factor 1-alpha (HIF-1α) expression compared to neutrophils from the bone marrow and blood of the same mouse. This enhanced glycolytic signature was also observed in human PDAC tissue samples. Strikingly, neutrophil-specific deletion of HIF-1α (HIF-1αΔNφ) significantly reduced tumor burden and improved overall survival in orthotopic transplanted mice, by converting the pro-tumorigenic neutrophil phenotype to an anti-tumorigenic phenotype. This outcome was associated with elevated reactive oxygen species production and activated natural killer cells and CD8+ cytotoxic T cells compared to littermate control mice. These data suggest a role for HIF-1α in neutrophil metabolism, which could be exploited as a target for metabolic modulation in cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![Figure 1 Pro-tumoral neutrophils infiltrate the pancreas of tumor-bearing mice and their persistent depletion improves tumor outcomes (a) Pancreatic tumors were harvested from day 28 tumor-bearing orthotopic transplanted (OT) mice, and the composition of the myeloid cell populations was assessed by flow cytometry. Scatter plot of neutrophils [Dapi-CD45 + Lin(CD3/B220/NK1.1) − Ly6G + Ly6C+] that infiltrate the pancreas are plotted as a percentage of total CD45+ cells, from OT (open circles) and age-matched sham non-tumor bearing controls (black circles). OT n = 15–17, sham n = 10; pooled from three independent experiments. (b) OT and control mice pancreata sections were stained for Dapi (blue) and Ly6G (red) expression. Representative immunofluorescence and H&E images of n = 3 experiments for each group. Scale bar = 100 µM. (c–e) Orthotopic tumors were generated in CXCR2−/− (blue circles) or control (black circles) mice. (c) Neutrophil infiltration into the pancreas was monitored at 6, 21 and 28 days post transplantation (CXCR2−/− n = 4, controls n = 7 per experiment for each time point). (d) Scatter plot of orthotopic tumor weights at 6, 14, 21, 28 and 35 days post transplantation (n = 3 mice per experiment for each time point). (e) Kaplan–Meier survival analysis of CXCR2−/− OT mice compared with control OT mice (n = 10). (f,g) OT mice were treated with α Ly-6G antibody (green) or isotype control antibody (black) via intraperitoneal (i.p.) injection thrice per week. (f) Neutrophil infiltration into the pancreas (plotted as a percentage of total CD45+ cells) was monitored at 6, 21 and 28 days post transplantation (n = 3–5 mice per experiment for each time point). (g) Scatter plot of orthotopic tumor weights at 6, 14, 21, 28 and 35 days post transplantation (n = 3 mice per experiment for each time point). (h) Kaplan–Meier survival analysis of α Ly-6G treated mice compared with isotype control treated mice (n = 10). Data represent the means ± SEM, * p < 0.05; ** p < 0.01; *** p < 0.001 by unpaired student’s t-test with a 95% confidence interval.](https://figures.cochat.ai/paper-figures/1859f6ae614740ed86617edfe930d49e/conditional-knockout-of-hypoxia-inducible-factor-1-alpha-in-tumor-infiltrating-figure-1.jpg)
![Figure 2 Pro-tumoral neutrophils exhibit a highly glycolytic signature and are adapted to a hypoxic tumor microenvironment (a–e) Bone marrow (BM), blood and tumor neutrophils were sorted based on their expression of Dapi-CD45 + Lin(CD3/B220/NK1.1) − Ly6G + Ly6C+ (orthotopic transplanted [OT] n = 5 mice pooled, three independent experiments). Hierarchical clustering and principal component analysis (PCA) were performed with log2–transformed values. (a) PCA plots of transcriptomic data of BM, blood and tumor neutrophils respectively. (b) Heat map of the differentially expressed genes selected with Benjamini–Hochberg adjusted p-values < 0.05. Four gene clusters (1 to 4) were manually defined and exported for gene ontology (GO) biological process analysis. (c) GO biological process terms enriched in clusters 1 (left) and 4 (right). (d,e) Expression of genes with row/gene-based z-score values (log2 FPKM) of cluster 4-associated genes across all sorted populations encoding (d) GO: 0006096—Glycolytic process and (e) GO: 0071456—Cellular response to hypoxia. (f) Representative immunofluorescence staining of pancreas sections from OT mice stained with Dapi (blue), S100A9 (red) neutrophil marker, and HIF-1α (green) and GLUT1 (cyan) glycolytic markers. Immunofluorescence images shown are representative images of n = 3 mice, and 10–15 fields of view. Scale bar = 100 µM. Scatter plots represent the mean fluorescence intensity (MFI) of HIF-1α+ neutrophils staining in the nucleus and cytoplasm, and percentage of GLUT1 expressing neutrophils in the tumor. Data represent the means ± SEM, *** p < 0.001 by unpaired Student’s t-test with a 95% confidence interval.](https://figures.cochat.ai/paper-figures/4164df4e9d9447e49fd7429895d88798/conditional-knockout-of-hypoxia-inducible-factor-1-alpha-in-tumor-infiltrating-figure-2.jpg)



![Figure 6 Anti-tumoral effector responses are supported by CD8+ T cells and NK cells activation and cytotoxicity (a) Bone marrow (BM), blood and tumor neutrophils were sorted based on their expression of Dapi-CD45 + Lin (CD3/B220/NK1.1) − Ly6G + Ly6C+ (orthotopic transplanted [OT] n = 5 mice pooled, three independent experiments). Gene analysis of Arg-1 was analyzed with log2-transformed values (log2RPKM). Data represent the means ± SEM, * p < 0.05; ** p < 0.01; *** p < 0.001 by one-way ANOVA, Tukey’s multiple comparisons test with a 95% confidence interval. (b) Pancreatic neutrophils were sorted from HIF-1αΔNφ and control mice, and gene expression of Ag1, (c) IL-12 and CCL5 was assessed by quantitative PCR (n = 3 mice, three independent experiments). (d) Representative flow cytometry plots from HIF-1αΔNφ and control neutrophils. Neutrophils were stimulated with 100 ng/mL LPS for 4 h and assessed for IL-12 and (e) TNF-α production by flow cytometry. Scatter plots indicate the percentage of total Ly6G+ cells, from HIF-1αΔNφ OT (red clear) and age-matched OT controls (black clear) (HIF-1αΔNφ n = 12, controls n = 10; of two independent experiments pooled). Data represent the means ± SEM, * p < 0.05; ** p < 0.01; *** p < 0.001 by unpaired Student’s t-test with 95% confidence interval.](https://figures.cochat.ai/paper-figures/b7afa972c6e94fafb92bb0113a91957e/conditional-knockout-of-hypoxia-inducible-factor-1-alpha-in-tumor-infiltrating-figure-6.jpg)

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Besides TAMs, HIF-1α is also known to promote the inflammatory response by promoting neutrophil survival, whereas HIF-1α depletion in tumor-infiltrating neutrophils can reverse their pro-tumorigenic phenotype, reducing tumor burden [78, 79].”
From The HIF Axes in Cancer - Angiogenesis, Metabolism and Immune-Modulation (2025) · cites this paper as [78]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Besides TAMs, HIF-1α is also known to promote the inflammatory response by promoting neutrophil survival, whereas HIF-1α depletion in tumor-infiltrating neutrophils can reverse their pro-tumorigenic phenotype, reducing tumor burden [78, 79].”
From The HIF Axes in Cancer - Angiogenesis, Metabolism and Immune-Modulation (2025) · cites this paper as [78]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Mantovani, A., Allavena, P., Sica, A., & Balkwill, F. (2008) · Nature · doi:10.1038/nature07205 · Cited by 11,399 · cited 1×
“Our hypothesis is consistent with studies describing the involvement of HIF-1α in glycolysis and induction of immune-cell activation [53,54].”
ResultSuccinate is an inflammatory signal that induces IL-1β through HIF-1α
Tannahill, G. M., Curtis, A. M., Adamik, J., Palsson-McDermott, E. M., McGettrick, A. F., Goel, G., Frezza, C., Bernard, N. J., Kelly, B., Foley, N. H., et al. (2013) · Nature · doi:10.1038/nature11986 · Cited by 4,176
Can the pharmaceutical industry reduce attrition rates?
Kola, I., & Landis, J. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1470 · Cited by 4,167
Polarization of Tumor-Associated Neutrophil Phenotype by TGF-β: “N1” versus “N2” TAN
Fridlender, Z. G., Sun, J., Kim, S., Kapoor, V., Cheng, G., Ling, L., Worthen, G. S., & Albelda, S. M. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.06.017 · Cited by 3,371
Metabolic Reprogramming: A Cancer Hallmark Even Warburg Did Not Anticipate
Ward, P. S., & Thompson, C. B. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.02.014 · Cited by 3,233 · cited 1×
“Tumor cells undergo increased aerobic glycolysis compared to healthy cells and release tumor-derived metabolites, such as lactic acid, into the tumor microenvironment [3].”
BackgroundCancer-related inflammation, the seventh hallmark of cancer: links to genetic instability
Colotta, F., Allavena, P., Sica, A., Garlanda, C., & Mantovani, A. (2009) · Carcinogenesis · doi:10.1093/carcin/bgp127 · Cited by 2,890
Hidalgo, M. (2010) · New England Journal of Medicine · doi:10.1056/nejmra0901557 · Cited by 2,570 · cited 1×
“Pancreatic ductal adenocarcinoma (PDAC) is a highly aggressive and comparably treatment-resistant pancreatic exocrine neoplasm [1].”
BackgroundPancreatic cancer genomes reveal aberrations in axon guidance pathway genes
Initiative, A. P. C. G., Biankin, A. V., Waddell, N., Kassahn, K. S., Gingras, M.-C., Muthuswamy, L. B., Johns, A. L., Miller, D. K., Wilson, P. J., Patch, A.-M., et al. (2012) · Nature · doi:10.1038/nature11547 · Cited by 2,058 · cited 1×
“Affected patients typically present with widespread metastases at the point of diagnosis, thus resulting in a poor prognosis [2].”
BackgroundHIF-1α is essential for myeloid cell-mediated inflammation
Cramer, T., Yamanishi, Y., Clausen, B. E., Förster, I., Pawlinski, R., Mackman, N., Haase, V. H., Jaenisch, R., Corr, M., Nizet, V., et al. (2003) · Cell · doi:10.1016/s0092-8674(03)00154-5 · Cited by 2,046
The Nature of Myeloid-Derived Suppressor Cells in the Tumor Microenvironment
Kumar, V., Patel, S., Tcyganov, E., & Gabrilovich, D. I. (2016) · Trends in Immunology · doi:10.1016/j.it.2016.01.004 · Cited by 2,008
Rodriguez, P. C., Quiceno, D. G., Zabaleta, J., Ortiz, B., Zea, A. H., Piazuelo, M. B., Delgado, A., Correa, P., Brayer, J., Sotomayor, E. M., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0465 · Cited by 1,276
Corzo, C. A., Condamine, T., Lu, L., Cotter, M. J., Youn, J.-I., Cheng, P., Cho, H.-I., Celis, E., Quiceno, D. G., Padhya, T., et al. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20100587 · Cited by 1,173
Metabolic Reprogramming of Macrophages
Freemerman, A. J., Johnson, A. R., Sacks, G. N., Milner, J. J., Kirk, E. L., Troester, M. A., Macintyre, A. N., Goraksha-Hicks, P., Rathmell, J. C., & Makowski, L. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.522037 · Cited by 947
Ziello, J. E., Jovin, I. S., & Huang, Y. (2007) · PubMed Central · Cited by 894
Hypoxia-induced neutrophil survival is mediated by HIF-1α–dependent NF-κB activity
Walmsley, S. R., Print, C., Farahi, N., Peyssonnaux, C., Johnson, R. S., Cramer, T., Sobolewski, A., Condliffe, A. M., Cowburn, A. S., Johnson, N., et al. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20040624 · Cited by 891
Metabolism of immune cells in cancer
Leone, R. D., & Powell, J. D. (2020) · Nature Reviews Cancer · doi:10.1038/s41568-020-0273-y · Cited by 877 · cited 1×
“Conceptual progress over the past decade has revealed that, similar to tumor cells, these immune cells exhibit specific metabolic profiles that influence their immunological functions [8].”
BackgroundSignal transduction to hypoxia-inducible factor 1
Semenza, G. L. (2002) · Biochemical Pharmacology · doi:10.1016/s0006-2952(02)01168-1 · Cited by 860 · cited 1×
“HIF-1α has been shown to activate hypoxia-responsive genes as one of the major mediators of hypoxic response [45,46].”
BackgroundImmune cell infiltration as an indicator of the immune microenvironment of pancreatic cancer
Ino, Y., Yamazaki-Itoh, R., Shimada, K., Iwasaki, M., Kosuge, T., Kanai, Y., & Hiraoka, N. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.32 · Cited by 849
Steele, C. W., Karim, S. A., Leach, J. D. G., Bailey, P., Upstill-Goddard, R., Rishi, L., Foth, M., Bryson, S., McDaid, K., Wilson, Z., et al. (2016) · Cancer Cell · doi:10.1016/j.ccell.2016.04.014 · Cited by 845
The neutrophil as a cellular source of chemokines
Scapini, P., Lapinet‐Vera, J. A., Gasperini, S., Calzetti, F., Bazzoni, F., & Cassatella, M. A. (2000) · Immunological Reviews · doi:10.1034/j.1600-065x.2000.17706.x · Cited by 802
Stack, E. C., Wang, C., Roman, K. A., & Hoyt, C. C. (2014) · Methods · doi:10.1016/j.ymeth.2014.08.016 · Cited by 768
Metabolic programming and PDHK1 control CD4+ T cell subsets and inflammation
Gerriets, V. A., Kishton, R. J., Nichols, A. G., Macintyre, A. N., Inoue, M., Ilkayeva, O., Winter, P. S., Liu, X., Priyadharshini, B., Slawinska, M. E., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci76012 · Cited by 731
Tumor-Associated Neutrophils: New Targets for Cancer Therapy
Gregory, A. D., & McGarry Houghton, A. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-2583 · Cited by 707
Evrard, M., Kwok, I. W. H., Chong, S. Z., Teng, K. W. W., Becht, E., Chen, J., Sieow, J. L., Penny, H. L., Ching, G. C., Devi, S., et al. (2018) · Immunity · doi:10.1016/j.immuni.2018.02.002 · Cited by 705
Self-citationRao, R. R., Li, Q., Odunsi, K., & Shrikant, P. A. (2010) · Immunity · doi:10.1016/j.immuni.2009.10.010 · Cited by 656 · cited 1×
“In addition, mTOR complex 1 influences CTL effector responses controlling their expression of cytolytic effector molecules [70].”
BackgroundHypoxia-inducible factors: cancer progression and clinical translation
Wicks, E. E., & Semenza, G. L. (2022) · Journal of Clinical Investigation · doi:10.1172/jci159839 · Cited by 580
PDK1-Dependent Metabolic Reprogramming Dictates Metastatic Potential in Breast Cancer
Dupuy, F., Tabariès, S., Andrzejewski, S., Dong, Z., Blagih, J., Annis, M. G., Omeroglu, A., Gao, D., Leung, S., Amir, E., et al. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.08.007 · Cited by 558
Nywening, T. M., Belt, B. A., Cullinan, D. R., Panni, R. Z., Han, B. J., Sanford, D. E., Jacobs, R. C., Ye, J., Patel, A. A., Gillanders, W. E., et al. (2018) · Gut · doi:10.1136/gutjnl-2017-313738 · Cited by 489
Highfill, S. L., Rodriguez, P. C., Zhou, Q., Goetz, C. A., Koehn, B. H., Veenstra, R., Taylor, P. A., Panoskaltsis-Mortari, A., Serody, J. S., Munn, D. H., et al. (2010) · Blood · doi:10.1182/blood-2010-06-287839 · Cited by 465
JunB Deficiency Leads to a Myeloproliferative Disorder Arising from Hematopoietic Stem Cells
Passegué, E., Wagner, E. F., & Weissman, I. L. (2004) · Cell · doi:10.1016/j.cell.2004.10.010 · Cited by 440
Neutrophils in Cancer: Two Sides of the Same Coin
Uribe-Querol, E., & Rosales, C. (2015) · Journal of Immunology Research · doi:10.1155/2015/983698 · Cited by 422
The Multifaceted Roles Neutrophils Play in the Tumor Microenvironment
Sionov, R. V., Fridlender, Z. G., & Granot, Z. (2015) · Cancer Microenvironment · doi:10.1007/s12307-014-0147-5 · Cited by 416
Fridlender, Z. G., Sun, J., Mishalian, I., Singhal, S., Cheng, G., Kapoor, V., Horng, W., Fridlender, G., Bayuh, R., Worthen, G. S., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0031524 · Cited by 311
Colom, B., Bodkin, J. V., Beyrau, M., Woodfin, A., Ody, C., Rourke, C., Chavakis, T., Brohi, K., Imhof, B. A., & Nourshargh, S. (2015) · Immunity · doi:10.1016/j.immuni.2015.05.010 · Cited by 270
Kishton, R. J., Barnes, C. E., Nichols, A. G., Cohen, S., Gerriets, V. A., Siska, P. J., Macintyre, A. N., Goraksha-Hicks, P., de Cubas, A. A., Liu, T., et al. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.03.008 · Cited by 260
Penny, H. L., Sieow, J. L., Adriani, G., Yeap, W. H., See Chi Ee, P., San Luis, B., Lee, B., Lee, T., Mak, S. Y., Ho, Y. S., et al. (2016) · OncoImmunology · doi:10.1080/2162402x.2016.1191731 · Cited by 254
Self-citationMishalian, I., Bayuh, R., Eruslanov, E., Michaeli, J., Levy, L., Zolotarov, L., Singhal, S., Albelda, S. M., Granot, Z., & Fridlender, Z. G. (2014) · International Journal of Cancer · doi:10.1002/ijc.28770 · Cited by 253
Li, Y., Patel, S. P., Roszik, J., & Qin, Y. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01591 · Cited by 195
Key role for neutrophils in radiation-induced antitumor immune responses: Potentiation with G-CSF
Takeshima, T., Pop, L. M., Laine, A., Iyengar, P., Vitetta, E. S., & Hannan, R. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1613187113 · Cited by 191
Rapisarda, A., Hollingshead, M., Uranchimeg, B., Bonomi, C. A., Borgel, S. D., Carter, J. P., Gehrs, B., Raffeld, M., Kinders, R. J., Parchment, R., et al. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-0274 · Cited by 171 · cited 1×
“Although targeting HIF-1α has its challenges, modulating HIF-1α, or its downstream effectors, can be therapeutically advantageous, as shown in some pre-clinical tumor models [66,67].”
BackgroundTLR9 ligation in pancreatic stellate cells promotes tumorigenesis
Zambirinis, C. P., Levie, E., Nguy, S., Avanzi, A., Barilla, R., Xu, Y., Seifert, L., Daley, D., Greco, S. H., Deutsch, M., et al. (2015) · Journal of Experimental Medicine · doi:10.1084/jem.20142162 · Cited by 164
Patil, R. S., Shah, S. U., Shrikhande, S. V., Goel, M., Dikshit, R. P., & Chiplunkar, S. V. (2016) · International Journal of Cancer · doi:10.1002/ijc.30134 · Cited by 159
The Role of Hypoxia Inducible Factor-1 in Hepatocellular Carcinoma
Luo, D., Wang, Z., Wu, J., Jiang, C., & Wu, J. (2014) · BioMed Research International · doi:10.1155/2014/409272 · Cited by 157
Reichel, C. A., Rehberg, M., Lerchenberger, M., Berberich, N., Bihari, P., Khandoga, A. G., Zahler, S., & Krombach, F. (2009) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.109.193268 · Cited by 151
Lagasse, E., & Weissman, I. (1992) · Blood · doi:10.1182/blood.v79.8.1907.1907 · Cited by 142
Hypoxia Inducible Factor Pathway Inhibitors as Anticancer Therapeutics
Burroughs, S. K., Kaluz, S., Wang, D., Wang, K., Van Meir, E. G., & Wang, B. (2013) · Future Medicinal Chemistry · doi:10.4155/fmc.13.17 · Cited by 140 · cited 2×
“HIF-1 inhibitors have been developed that act upstream of HIF-1α protein synthesis, HIF-1α stabilization and dimerization and their interactions with other proteins [64].”
BackgroundMetabolism addiction in pancreatic cancer
Blum, R., & Kloog, Y. (2014) · Cell Death & Disease · doi:10.1038/cddis.2014.38 · Cited by 134
Molecular mechanisms of neutrophil dysfunction in glycogen storage disease type Ib
Jun, H. S., Weinstein, D. A., Lee, Y. M., Mansfield, B. C., & Chou, J. Y. (2014) · Blood · doi:10.1182/blood-2013-05-502435 · Cited by 130
Graham, D. B., Robertson, C. M., Bautista, J., Mascarenhas, F., Diacovo, M. J., Montgrain, V., Lam, S. K., Cremasco, V., Dunne, W. M., Faccio, R., et al. (2007) · Journal of Clinical Investigation · doi:10.1172/jci32729 · Cited by 124 · cited 1×
“Reactive oxygen species (ROS) have a known role in anti-tumoral immunity [29], and one of the main neutrophil effector functions is oxidative burst [30].”
BackgroundFelix, K., & Gaida, M. M. (2016) · International Journal of Biological Sciences · doi:10.7150/ijbs.14996 · Cited by 120
Warburg, O. H., Gawehn, K., & Geissler, A.-W. (1958) · PubMed · Cited by 111
Robinson, J. M., Karnovsky, M. L., & Karnovsky, M. J. (1982) · The Journal of Cell Biology · doi:10.1083/jcb.95.3.933 · Cited by 97
Extracellular Flux Analysis to Monitor Glycolytic Rates and Mitochondrial Oxygen Consumption
Pelletier, M., Billingham, L. K., Ramaswamy, M., & Siegel, R. M. (2014) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/b978-0-12-416618-9.00007-8 · Cited by 96
Prognostic value of tumor-associated macrophages in pancreatic cancer: a meta-analysis
Yu, M., Guan, R., Hong, W., Zhou, Y., Lin, Y., Jin, H., Hou, B., & Jian, Z. (2019) · Cancer Management and Research · doi:10.2147/cmar.s196951 · Cited by 92
Schouppe, E., BAETSELIER, P. D., Ginderachter, J. A. V., & Sarukhan, A. (2012) · OncoImmunology · doi:10.4161/onci.21566 · Cited by 89
Eissens, D., van der Meer, A., van Cranenbroek, B., Preijers, F. W. M. B., & Joosten, I. (2010) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2010.03242.x · Cited by 74
Ly6G-mediated depletion of neutrophils is dependent on macrophages
Bruhn, K. W., Dekitani, K., Nielsen, T. B., Pantapalangkoor, P., & Spellberg, B. J. (2015) · Results in Immunology · doi:10.1016/j.rinim.2015.12.001 · Cited by 69
Utility of multispectral imaging in automated quantitative scoring of immunohistochemistry
Fiore, C., Bailey, D., Conlon, N., Wu, X., Martin, N., Fiorentino, M., Finn, S. P., Fall, K., Andersson, S., Andrén, O., et al. (2012) · Journal of Clinical Pathology · doi:10.1136/jclinpath-2012-200734 · Cited by 62
mTOR Regulation of Lymphoid Cells in Immunity to Pathogens
Keating, R., & McGargill, M. A. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00180 · Cited by 51
Xue, M., Thakur, A. B., Cole, N., Lloyd, A. R., Stapleton, F. J., Wakefield, D., & Willcox, M. D. P. (2007) · Immunology and Cell Biology · doi:10.1038/sj.icb.7100082 · Cited by 50
Understanding the Tumor Metabolic Phenotype in the Genomic Era
Stubbs, M., Bashford, C., & Griffiths, J. (2003) · Current Molecular Medicine · doi:10.2174/1566524033361645 · Cited by 48
Kolb, A., Rieder, S., Born, D., Giese, N. A., Giese, T., Rudofsky, G., Werner, J., Büchler, M. W., Friess, H., Esposito, I., et al. (2009) · Cancer Biology & Therapy · doi:10.4161/cbt.8.16.9006 · Cited by 47
Restoring Retinoic Acid Attenuates Intestinal Inflammation and Tumorigenesis in APCMin/+ Mice
Penny, H. L., Prestwood, T. R., Bhattacharya, N., Sun, F., Kenkel, J. A., Davidson, M. G., Shen, L., Zuniga, L. A., Seeley, E. S., Pai, R., et al. (2016) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-15-0038 · Cited by 46
Self-citationHypoxia-inducible factor (HIF) inhibitors: a patent survey (2011-2015)
Ban, H. S., Uto, Y., Won, M., & Nakamura, H. (2016) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.2016.1146252 · Cited by 44
Neutrophils assist the metastasis of circulating tumor cells in pancreatic ductal adenocarcinoma
Tao, L., Zhang, L., Peng, Y., Tao, M., Li, L., Xiu, D., Yuan, C., Ma, Z., & Jiang, B. (2016) · Medicine · doi:10.1097/md.0000000000004932 · Cited by 44
Romano, A., Parrinello, N. L., Vetro, C., Tibullo, D., Giallongo, C., Cava, P. L., Chiarenza, A., Motta, G., Caruso, A. L., Villari, L., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.12024 · Cited by 41
Targeting Glycolysis in Macrophages Confers Protection Against Pancreatic Ductal Adenocarcinoma
Penny, H. L., Sieow, J. L., Gun, S. Y., Lau, M. C., Lee, B. T. K., Tan, J., Phua, C., Toh, F., Nga, Y., Yeap, W. H., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22126350 · Cited by 40
Self-citationIL-12 induces specific cytotoxicity against regenerating hepatocytes in vivo
Matsushita, T., Ando, K., Kimura, K., Ohnishi, H., Imawari, M., Muto, Y., & Moriwaki, H. (1999) · International Immunology · doi:10.1093/intimm/11.5.657 · Cited by 34
Hypoxia inducible factors are dispensable for myeloid cell migration into the inflamed mouse eye
Gardner, P. J., Liyanage, S. E., Cristante, E., Sampson, R. D., Dick, A. D., Ali, R. R., & Bainbridge, J. W. (2017) · Scientific Reports · doi:10.1038/srep40830 · Cited by 9
Cited by
The HIF Axes in Cancer - Angiogenesis, Metabolism and Immune-Modulation
Acuña-Pilarte, K., & Koh, M. Y. (2025) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2025.06.005 · Cited by 64
Emerging roles of MITF as a crucial regulator of immunity
Lee, A., Lim, J., & Lim, J. (2024) · Experimental & Molecular Medicine · doi:10.1038/s12276-024-01175-5 · Cited by 42
Yang, Y., Shao, X., Li, Z., Zhang, L., Yang, B., Jin, B., Hu, X., Qu, X., Che, X., & Liu, Y. (2024) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.18521 · Cited by 25
Tumour‐associated neutrophils: Potential therapeutic targets in pancreatic cancer immunotherapy
Wu, Q., Mao, H., Jiang, Z., & Tang, D. (2024) · Immunology · doi:10.1111/imm.13765 · Cited by 13
Imaging glucose metabolism to reveal tumor progression
Meng, Y., Sun, J., Zhang, G., Yu, T., & Piao, H. (2023) · Frontiers in Physiology · doi:10.3389/fphys.2023.1103354 · Cited by 10
“In contrast, most cancer cells rely on aerobic glycolysis, a phenomenon known as the “Warburg effect” (Sieow et al., 2023).”
Background
Metadata
- Authors
- Sieow, J. L., Penny, H. L., Gun, S. Y., Tan, L. Q., Duan, K., Yeong, J. P. S., Pang, A., Lim, D., Toh, H. C., Lim, T. K. H., Engleman, E., Rotzschke, O., Ng, L. G., Chen, J., Tan, S. M., & Wong, S. C.
- Affiliations
- Agency for Science, Technology and Research (SG)
- National University Cancer Institute, Singapore (SG)
- National University Health System (SG)
- National Cancer Centre Singapore (SG)
- Singapore General Hospital (SG)
- Stanford Medicine (US)
- Singapore Immunology Network, Agency for Science, Technology and Research (A*STAR), Singapore 138648, Singapore
- Nanyang Technological University (SG)
- Corresponding author
- Wong, Siew Cheng
- ORCID
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2023-01-01
- Volume
- 24
- Issue
- 1
- Pages
- 753
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC9821271
- OpenAlex
- W4313472601
- Cited by
- 27
- References
- 72
- Citations by year
- 2026: 7 · 2025: 5 · 2024: 13 · 2023: 2
- FWCI
- 3.07
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DR-NTU (Nanyang Technological University) (submittedVersion, cc-by)
- National University of Singapore (submittedVersion)
- Funders
- Biomedical Research Council
- A*STAR
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Health Sciences › Medicine › Oncology › Pancreatic and Hepatic Oncology Research
- Keywords
- hypoxia-inducible factor-1α, tumor-infiltrating neutrophils, pancreatic ductal adenocarcinoma, neutrophil metabolism, glycolysis, tumor microenvironment, neutrophil reprogramming, reactive oxygen species, natural killer cells, CD8+ T cells, tumor immunology, metabolic cancer therapy
- MeSH terms
- Animals, Humans, Neutrophils, Pancreatic Neoplasms, Mice, Knockout, Carcinoma, Pancreatic Ductal, Cell Line, Tumor, Mice, Hypoxia-Inducible Factor 1, Hypoxia-Inducible Factor 1, alpha Subunit, Tumor Microenvironment, Carcinogenesis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.